Table of Contents
ISRN Neurology
Volume 2011, Article ID 904706, 4 pages
http://dx.doi.org/10.5402/2011/904706
Research Article

Optic Nerve and Spinal Cord Are the Major Lesions in Each Relapse of Japanese Multiple Sclerosis

Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai Fuchu, Tokyo 183-0042, Japan

Received 10 June 2011; Accepted 7 July 2011

Academic Editors: P. Annunziata and J. Haas

Copyright © 2011 Yoko Warabi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Wingerchuk, W. F. Hogancamp, P. C. O'Brien, and B. G. Weinshenker, “The clinical course of neuromyelitis optica (Devic's syndrome),” Neurology, vol. 53, no. 5, pp. 1107–1114, 1999. View at Google Scholar · View at Scopus
  2. D. M. Wingerchuk, V. A. Lennon, C. F. Lucchinetti, S. J. Pittock, and B. G. Weinshenker, “The spectrum of neuromyelitis optica,” Lancet Neurology, vol. 6, no. 9, pp. 805–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Fukazawa, S. Kikuchi, R. Miyagishi et al., “CSF pleocytosis and expansion of spinal lesions in Japanese multiple sclerosis with special reference to the new diagnostic criteria,” Journal of Neurology, vol. 252, no. 7, pp. 824–829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. V. A. Lennon, T. J. Kryzer, S. J. Pittock, A. S. Verkman, and S. R. Hinson, “IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel,” Journal of Experimental Medicine, vol. 202, no. 4, pp. 473–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Misu, K. Fujihara, A. Kakita et al., “Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis,” Brain, vol. 130, no. 5, pp. 1224–1234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria,” Annals of Neurology, vol. 69, no. 2, pp. 292–302, 2011. View at Publisher · View at Google Scholar
  7. J. Kira, T. Kanai, Y. Nishimura et al., “Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders,” Annals of Neurology, vol. 40, no. 4, pp. 569–574, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Yamasaki, I. Horiuchi, M. Minohara et al., “HLA-DPB10501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies,” Brain, vol. 122, no. 9, pp. 1689–1696, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Matsushita, T. Matsuoka, N. Isobe et al., “Association of the HLA-DPB10501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders,” Tissue Antigens, vol. 73, no. 2, pp. 171–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Warabi, K. Yagi, and H. Hayashi, “Multiple sclerosis in Tokyo Metropolitan Neurological Hospital: from the view points of north latitude and Japan's rapid economic growth,” Clinical Neurology, vol. 43, no. 7, pp. 432–433, 2003. View at Google Scholar · View at Scopus
  11. W. I. McDonald, A. Compston, G. Edan et al., “Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis,” Annals of Neurology, vol. 50, no. 1, pp. 121–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Shibasaki, W. I. McDonald, and Y. Kuroiwa, “Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients,” Journal of the Neurological Sciences, vol. 49, no. 2, pp. 253–271, 1981. View at Publisher · View at Google Scholar · View at Scopus
  13. D. W. Paty and G. C. Ebers, Multiple Sclerosis, F.A. Davis Company, Philadelphia, Pa, USA, 1998.
  14. L. T. Nguyen, M. Ramanathan, B. Weinstock-Guttman, M. Baier, C. Brownscheidle, and L. D. Jacobs, “Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients,” Journal of the Neurological Sciences, vol. 209, no. 1-2, pp. 93–99, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Saida, K. Tashiro, Y. Itoyama, T. Sato, Y. Ohashi, and Z. Zhao, “Interferon β-1b is effective in Japanese RRMS patients: a randomized, multicenter study,” Neurology, vol. 64, no. 4, pp. 621–630, 2005. View at Google Scholar · View at Scopus
  16. Y. Warabi, Y. Matsumoto, and H. Hayashi, “Interferon β-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination,” Journal of the Neurological Sciences, vol. 252, no. 1, pp. 57–61, 2007. View at Publisher · View at Google Scholar · View at Scopus